Cargando…

Increased Adipocyte Hypertrophy in Patients with Nascent Metabolic Syndrome

Background and Aims: Metabolic Syndrome (MetS), a global problem, predisposes to an increased risk for type 2 diabetes and premature cardiovascular disease. While MetS is associated with central obesity, there is scanty data on adipocyte hypertrophy, increased fat cell size (FCS), in MetS. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jialal, Ishwarlal, Adams-Huet, Beverley, Devaraj, Sridevi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342593/ https://www.ncbi.nlm.nih.gov/pubmed/37445281 http://dx.doi.org/10.3390/jcm12134247

Ejemplares similares

Correlates of Insulin Resistance in Nascent Metabolic Syndrome
por: Adams-Huet, Beverley, et al.
Publicado: (2023)

Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome
por: Jialal, Ishwarlal, et al.
Publicado: (2012)

Dysfunctional Endothelial Progenitor Cells in Metabolic Syndrome
por: Devaraj, Sridevi, et al.
Publicado: (2012)

Adipose Tissue Dysfunction in Nascent Metabolic Syndrome
por: Bremer, Andrew A., et al.
Publicado: (2013)

Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome
por: Devaraj, Sridevi, et al.
Publicado: (2010)

Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?
por: Devaraj, Sridevi, et al.
Publicado: (2010)

Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323
por: Jialal, Ishwarlal, et al.
Publicado: (2014)

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
por: Dasu, Mohan R., et al.
Publicado: (2010)

SAT-656 Both Neutrophil and Monocyte Ratios to High Density Lipoprotein Cholesterol Are Superior Biomarkers of Metabolic Syndrome
por: Ramakrishnan, Neeraj, et al.
Publicado: (2020)

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation
por: Dasu, Mohan R., et al.
Publicado: (2008)

Gut Microbiome and Inflammation: A Study of Diabetic Inflammasome-Knockout Mice
por: Pahwa, Roma, et al.
Publicado: (2017)

Exploratory metabolomics of metabolic syndrome: A status report
por: Lent-Schochet, Daniella, et al.
Publicado: (2019)

Management of Hypertriglyceridemia in the Diabetic Patient
por: Jialal, Ishwarlal, et al.
Publicado: (2010)

Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy
por: Rajamani, Uthra, et al.
Publicado: (2014)

Bempedoic Acid, an Inhibitor of Cholesterol Biosynthesis, Reduces Cardiovascular Events
por: Jialal, Ishwarlal, et al.
Publicado: (2023)

Erratum to “Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy”
por: Rajamani, Uthra, et al.
Publicado: (2016)

Fetuin-A is also an adipokine
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Management of diabetic dyslipidemia: An update
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen?
por: Jialal, Ishwarlal, et al.
Publicado: (2021)

Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy
por: Gonzales, Amanda M, et al.
Publicado: (2007)

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes
por: Devaraj, S., et al.
Publicado: (2009)

Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism
por: Geoghegan, Gisela, et al.
Publicado: (2019)

Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
por: Kusaka, Hiroaki, et al.
Publicado: (2016)

Use of Apolipoprotein B in the Era of Precision Medicine: Time for a Paradigm Change?
por: Cole, Justine, et al.
Publicado: (2023)

Mirtazapine Reduces Adipocyte Hypertrophy and Increases Glucose Transporter Expression in Obese Mice
por: Wu, Ching-Feng, et al.
Publicado: (2020)

Intra-Abdominal Fat Adipocyte Hypertrophy through a Progressive Alteration of Lipolysis and Lipogenesis in Metabolic Syndrome Rats
por: Pérez-Torres, Israel, et al.
Publicado: (2019)

Adipocyte Dysfunction in a Mouse Model of Polycystic Ovary Syndrome (PCOS): Evidence of Adipocyte Hypertrophy and Tissue-Specific Inflammation
por: Marino, Joseph S., et al.
Publicado: (2012)

Effects of the Angiotensin Receptor Blocker Olmesartan on Adipocyte Hypertrophy and Function in Mice with Metabolic Disorders
por: Maeda, Akinobu, et al.
Publicado: (2014)

Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
por: Nassour, Ibrahim, et al.
Publicado: (2017)

Obesity, Metabolic Syndrome, and Adipocytes
por: Dodson, M. V., et al.
Publicado: (2011)

High LPL Activity and Adipocyte Hypertrophy Reduce Visceral Fat and Metabolic Risk in Obese, Older Women
por: Serra, Monica C., et al.
Publicado: (2015)

Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-.Leiden Mice
por: Pelgrim, Charlotte E., et al.
Publicado: (2017)

Adipocyte-specific expression of C-type natriuretic peptide suppresses lipid metabolism and adipocyte hypertrophy in adipose tissues in mice fed high-fat diet
por: Bae, Cho-Rong, et al.
Publicado: (2018)

Dilated Blood and Lymphatic Microvessels, Angiogenesis, Increased Macrophages, and Adipocyte Hypertrophy in Lipedema Thigh Skin and Fat Tissue
por: AL-Ghadban, Sara, et al.
Publicado: (2019)

Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
por: Holmer, Magnus, et al.
Publicado: (2022)

Macadamia Oil Supplementation Attenuates Inflammation and Adipocyte Hypertrophy in Obese Mice
por: Lima, Edson A., et al.
Publicado: (2014)

Impact of Time-Restricted Feeding and Dawn-to-Sunset Fasting on Circadian Rhythm, Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease
por: Mindikoglu, Ayse L., et al.
Publicado: (2017)

Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese
por: Yu, Shasha, et al.
Publicado: (2020)

Dietary-challenged mice with Alzheimer-like pathology show increased energy expenditure and reduced adipocyte hypertrophy and steatosis
por: Schreyer, Stefanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fh2k8336qii0kbgeslgdloal4m